Inventor · disambiguated record
Daniel Jon Sall
Also filed as: RUEHTER GERD · SALL DANIEL J · SALL DANIEL JON
70 granted patents·4 pending applications·574 citations·filing 1993–2023
99Inventor score
Top patents by PatentIndex Score
74 records- 0197US10654866B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2019·Granted May 19, 2020·15 cites·19 claims
- 0296US11117902B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2020·Granted Sep 14, 2021·6 cites·16 claims
- 0395US11634426B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2021·Granted Apr 25, 2023·3 cites·20 claims
- 0490US6177440B1Substituted tricyclicsLILLY CO ELI·Filed 1998·Granted Jan 23, 2001·60 cites·32 claims
- 0588US5618843AGlycoprotein IIb/IIIa antagonistsLILLY CO ELI·Filed 1994·Granted Apr 8, 1997·34 cites·15 claims
- 0687US9872853B22,3-dihydro-1H-indole compoundsLILLY CO ELI·Filed 2017·Granted Jan 23, 2018·4 cites·8 claims
- 0787US6825220B23-Substituted oxindole β 3 agonistsLILLY CO ELI·Filed 2001·Granted Nov 30, 2004·18 cites·10 claims
- 0887US6713645B1Substituted tricyclicsLILLY CO ELI·Filed 2000·Granted Mar 30, 2004·21 cites·2 claims
- 0986US5731324AGlycoprotein IIb/IIIa antagonistsLILLY CO ELI·Filed 1995·Granted Mar 24, 1998·37 cites·24 claims
- 1085US10759786B21-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancerLILLY CO ELI·Filed 2017·Granted Sep 1, 2020·3 cites·5 claims
- 1185US7087635B23-substituted oxindole β3 agonistsLILLY CO ELI·Filed 2005·Granted Aug 8, 2006·10 cites·4 claims
- 1284US6872743B2sPLA2 inhibitorsLILLY CO ELI·Filed 2001·Granted Mar 29, 2005·21 cites·18 claims
- 1384US6730792B2β3 adrenergic agonistsLILLY CO ELI·Filed 2001·Granted May 4, 2004·21 cites·17 claims
- 1484US6137002AGlycoprotein IIb/IIIa antagonistsLILLY CO ELI·Filed 1996·Granted Oct 24, 2000·28 cites·12 claims
- 1582US11993608B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2023·Granted May 28, 2024·0 cites·12 claims
- 1681US6911463B23-substituted oxindole β-3 agonistsLILLY CO ELI·Filed 2002·Granted Jun 28, 2005·11 cites·7 claims
- 1780US5488037AAntithrombotic agentsLILLY CO ELI·Filed 1994·Granted Jan 30, 1996·20 cites·35 claims
- 1878US5441965AMethods of inhibiting thrombinLILLY CO ELI·Filed 1993·Granted Aug 15, 1995·39 cites·3 claims
- 1977US6448269B1Glycoprotein IIb/IIIa antagonistsLILLY CO ELI·Filed 2001·Granted Sep 10, 2002·7 cites·18 claims
- 2074US6025382AAntithrombotic diaminesLILLY CO ELI·Filed 1997·Granted Feb 15, 2000·15 cites·21 claims
- 2172US7109231B2Cyclohept[b]indole derivativesLILLY CO ELI·Filed 2002·Granted Sep 19, 2006·6 cites·16 claims
- 2272US7071208B2β3 Adrenergic agonistsLILLY CO ELI·Filed 2002·Granted Jul 4, 2006·4 cites·5 claims
- 2371US7160909B2Cyclopenta[b]indole derivatives as sPLA2 inhibitorsLILLY CO ELI·Filed 2002·Granted Jan 9, 2007·5 cites·13 claims
- 2470US6992100B2sPLA2 inhibitorsLILLY CO ELI·Filed 2001·Granted Jan 31, 2006·3 cites·19 claims
- 2569US6472405B1Glycoprotein IIB/IIIA antagonistsLILLY CO ELI·Filed 1999·Granted Oct 29, 2002·22 cites·37 claims
- 2668US7122680B23-Substituted oxindole β3 agonsistsLILLY CO ELI·Filed 2004·Granted Oct 17, 2006·3 cites·4 claims
- 2768US6274616B1N,N-diethylglycolamido ester prodrugs of indole sPLA2 inhibitorsLILLY CO ELI·Filed 2000·Granted Aug 14, 2001·3 cites·6 claims
- 2868US5508292AMethods of inhibiting thrombinLILLY CO ELI·Filed 1995·Granted Apr 16, 1996·24 cites·4 claims
- 2965US6974831B2sPLA2 inhibitorsLILLY CO ELI·Filed 2001·Granted Dec 13, 2005·2 cites·17 claims
- 3065US6930123B2sPLA2 inhibitorsLILLY CO ELI·Filed 2001·Granted Aug 16, 2005·2 cites·13 claims
- 3165US6916840B2Spla2 inhibitorsLILLY CO ELI·Filed 2001·Granted Jul 12, 2005·2 cites·13 claims
- 3264US10323019B2Pyrazolylaminobenzimidazole derivatives as JAK inhibitorsLILLY CO ELI·Filed 2017·Granted Jun 18, 2019·0 cites·18 claims
- 3364US6541499B1Antithrombotic agentsLILLY CO ELI·Filed 1998·Granted Apr 1, 2003·11 cites·10 claims
- 3462US12128040B2Selective estrogen receptor degradersLILLY CO ELI·Filed 2019·Granted Oct 29, 2024·0 cites·7 claims
- 3562US6448284B1Substituted tricyclicsLILLY CO ELI·Filed 1999·Granted Sep 10, 2002·17 cites·21 claims
- 3662US5710285AProcess for preparing 2-substituted benzo B!thiophene compounds and intermediates thereofLILLY CO ELI·Filed 1995·Granted Jan 20, 1998·6 cites·8 claims
- 3762US5484772AAntithrombotic agentsLILLY CO ELI·Filed 1994·Granted Jan 16, 1996·19 cites·55 claims
- 3860US10344018B2Pyrazolylaminobenzimidazole derivatives as JAK inhibitorsLILLY CO ELI·Filed 2019·Granted Jul 9, 2019·0 cites·9 claims
- 3960US7297706B2Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disordersLILLY CO ELI·Filed 2006·Granted Nov 20, 2007·0 cites·13 claims
- 4060US7253181B2β3 adrenergic agonistsLILLY CO ELI·Filed 2006·Granted Aug 7, 2007·0 cites·6 claims
- 4159US7265127B2β3 adrenergic agonistsLILLY CO ELI·Filed 2006·Granted Sep 4, 2007·0 cites·6 claims
- 4259US7241772B2β3 adrenergic agonistsLILLY CO ELI·Filed 2006·Granted Jul 10, 2007·0 cites·4 claims
- 4358US6020362AGlycoprotein IIB IIIA antagonistsLILLY CO ELI·Filed 1998·Granted Feb 1, 2000·6 cites·24 claims
- 4457US6350774B1Antithrombotic agentsLILLY CO ELI·Filed 1998·Granted Feb 26, 2002·7 cites·20 claims
- 4556US6620837B1Antithrombotic agentsLILLY CO ELI·Filed 2000·Granted Sep 16, 2003·1 cites·16 claims
- 4655US5688813AMethods of inhibiting thrombinLILLY CO ELI·Filed 1995·Granted Nov 18, 1997·12 cites·3 claims
- 4754US8445493B2Tetrasubstituted pyridazines hedgehog pathway antagonistsBASTIAN JOLIE ANNE·Filed 2009·Granted May 21, 2013·0 cites·9 claims
- 4854US6177426B1Morpholino-N-ethyl ester prodrugs of indole sPLA2 inhibitorsLILLY CO ELI·Filed 1998·Granted Jan 23, 2001·10 cites·5 claims
- 4954US2022288019A1Methods of treating cancer using a combination of SERD Dosing RegimensLILLY CO ELI·Filed 2022·Application pending·0 cites
- 5052US5578574AAntithrombotic agentsLILLY CO ELI·Filed 1995·Granted Nov 26, 1996·9 cites·25 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel Jon Sall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →